Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 1
1973 7
1974 5
1975 3
1976 5
1977 4
1978 6
1979 5
1980 1
1981 6
1982 6
1983 6
1984 6
1985 5
1986 10
1987 8
1988 5
1989 11
1990 6
1991 9
1992 10
1993 10
1994 3
1995 17
1996 13
1997 18
1998 10
1999 14
2000 17
2001 12
2002 11
2003 9
2004 8
2005 7
2006 6
2007 7
2008 3
2009 7
2010 10
2011 5
2012 5
2013 6
2014 3
2015 3
2016 3
2017 1
2018 3
2019 1
2020 2
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. Among authors: schellhammer pf. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Sipuleucel-T.
Higano CS, Small EJ, Schellhammer P, Yasothan U, Gubernick S, Kirkpatrick P, Kantoff PW. Higano CS, et al. Among authors: schellhammer p. Nat Rev Drug Discov. 2010 Jul;9(7):513-4. doi: 10.1038/nrd3220. Nat Rev Drug Discov. 2010. PMID: 20592741 No abstract available.
Editorial comment.
Schellhammer PF. Schellhammer PF. J Urol. 2011 Mar;185(3):854; author reply 854. doi: 10.1016/j.juro.2010.10.091. Epub 2011 Jan 15. J Urol. 2011. PMID: 21239016 No abstract available.
Legends in Urology.
Schellhammer PF. Schellhammer PF. Can J Urol. 2016 Jun;23(3):8261-4. Can J Urol. 2016. PMID: 27347617 Free article. No abstract available.
A Urologist's Personal View of Prostate Cancer.
Schellhammer PF. Schellhammer PF. Turk J Urol. 2016 Sep;42(3):121-6. doi: 10.5152/tud.2016.50318. Turk J Urol. 2016. PMID: 27635283 Free PMC article. Review.
A history of the Society of Urologic Oncology.
Lange PH, Cookson MS, Schellhammer PF, Droller MJ. Lange PH, et al. Among authors: schellhammer pf. Urol Oncol. 2021 Sep;39(9):514-520. doi: 10.1016/j.urolonc.2020.12.018. Epub 2021 Jan 13. Urol Oncol. 2021. PMID: 33454198
Metastatic castrate-resistant prostate cancer.
Schellhammer P. Schellhammer P. Urol Oncol. 2015 Jan;33(1):51-52. doi: 10.1016/j.urolonc.2014.07.006. Epub 2014 Sep 3. Urol Oncol. 2015. PMID: 25192835 No abstract available.
Five-alpha-reductase Inhibitors for prostate cancer prevention.
Wilt TJ, MacDonald R, Hagerty K, Schellhammer P, Kramer BS. Wilt TJ, et al. Among authors: schellhammer p. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007091. doi: 10.1002/14651858.CD007091. Cochrane Database Syst Rev. 2008. PMID: 18425978 Review.
Prostatic carcinoma.
Lawton CA, Grignon D, Newhouse JH, Schellhammer PF, Kuban DA. Lawton CA, et al. Among authors: schellhammer pf. Radiographics. 1999 Jan-Feb;19(1):185-203. doi: 10.1148/radiographics.19.1.g99ja08185. Radiographics. 1999. PMID: 9925399 No abstract available.
335 results